• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

An academic hospital experience screening mRNA COVID-19 vaccine risk using patient allergy history.

作者信息

Krantz Matthew S, Stone Cosby A, Rolando Lori A, Nobis Ana E, Koo Grace, Corey Kristen B, Bluestein Sara B, Staso Patrick J, Campbell Emily M, Phillips Elizabeth J

机构信息

Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn.

Vanderbilt Occupational Health Clinic, Vanderbilt Health & Wellness, Vanderbilt University Medical Center, Nashville, Tenn; Division of General Internal Medicine and Public Health, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn.

出版信息

J Allergy Clin Immunol Pract. 2021 Oct;9(10):3807-3810. doi: 10.1016/j.jaip.2021.07.010. Epub 2021 Jul 19.

DOI:10.1016/j.jaip.2021.07.010
PMID:34293499
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8288228/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/856d/8288228/0e383551a612/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/856d/8288228/c49db1f46ba0/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/856d/8288228/0e383551a612/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/856d/8288228/c49db1f46ba0/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/856d/8288228/0e383551a612/gr2_lrg.jpg

相似文献

1
An academic hospital experience screening mRNA COVID-19 vaccine risk using patient allergy history.一家学术医院利用患者过敏史筛查新冠病毒mRNA疫苗风险的经历。
J Allergy Clin Immunol Pract. 2021 Oct;9(10):3807-3810. doi: 10.1016/j.jaip.2021.07.010. Epub 2021 Jul 19.
2
[Not Available].[无可用内容]
Laryngorhinootologie. 2021 May;100(5):344-354. doi: 10.1055/a-1397-0754. Epub 2021 Mar 8.
3
IgE-mediated allergy to polyethylene glycol (PEG) as a cause of anaphylaxis to mRNA COVID-19 vaccines.作为对mRNA新冠疫苗过敏反应的一个原因，IgE介导的对聚乙二醇（PEG）过敏
Clin Exp Allergy. 2022 Jan;52(1):10-11. doi: 10.1111/cea.13995. Epub 2021 Sep 21.
4
Anaphylaxis is a rare reaction in COVID-19 vaccination.在 COVID-19 疫苗接种中，过敏反应较为罕见。
J Biol Regul Homeost Agents. 2021 May-Jun;35(3):839-842. doi: 10.23812/BELLOMO_EDIT_3_21.
5
First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing.mRNA COVID-19 疫苗首剂过敏反应：赋形剂皮肤试验作用有限。
J Allergy Clin Immunol Pract. 2021 Sep;9(9):3308-3320.e3. doi: 10.1016/j.jaip.2021.06.010. Epub 2021 Jun 22.
6
Anaphylactic reactions to mRNA COVID-19 vaccines: A call for further study.对新冠mRNA疫苗的过敏反应：呼吁进一步研究。
Vaccine. 2021 May 6;39(19):2605-2607. doi: 10.1016/j.vaccine.2021.03.073. Epub 2021 Apr 6.
7
mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis.mRNA新冠疫苗在患有皮肤和全身性肥大细胞增多症且伴有肥大细胞活化症状和过敏反应的患者中耐受性良好。
J Allergy Clin Immunol. 2021 Mar;147(3):877-878. doi: 10.1016/j.jaci.2021.01.004. Epub 2021 Jan 19.
8
Insights from American College of Allergy, Asthma, and Immunology COVID-19 Vaccine Task Force: Allergic Reactions to mRNA SARS-CoV-2 Vaccines.美国过敏、哮喘与免疫学会2019冠状病毒病疫苗特别工作组见解：对mRNA新型冠状病毒疫苗的过敏反应
Ann Allergy Asthma Immunol. 2021 Apr;126(4):319-320. doi: 10.1016/j.anai.2021.01.017. Epub 2021 Jan 23.
9
Effectiveness of Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Cohort of Healthcare Personnel.信使 RNA 新冠病毒 2019 疾病（COVID-19）疫苗对医护人员队列中严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）感染的有效性。
Clin Infect Dis. 2021 Sep 15;73(6):e1376-e1379. doi: 10.1093/cid/ciab361.
10
Sex differences in the incidence of anaphylaxis to LNP-mRNA COVID-19 vaccines.脂质纳米颗粒信使核糖核酸新冠疫苗过敏反应发生率的性别差异。
Vaccine. 2021 Jun 8;39(25):3313-3314. doi: 10.1016/j.vaccine.2021.04.066. Epub 2021 May 6.

引用本文的文献

1
Vaccine confidence among those living with allergy during the COVID pandemic (ACCORD): A scoping review.新冠疫情期间过敏症患者的疫苗信心（ACCORD）：一项范围综述
J Allergy Clin Immunol Glob. 2023 May;2(2):100079. doi: 10.1016/j.jacig.2023.100079. Epub 2023 Feb 8.
2
Vaccination counseling with and without excipient skin testing in patients with suspected allergic reactions to mRNA COVID-19 vaccines and patients with atopy.对疑似对mRNA新冠疫苗有过敏反应的患者和特应性患者进行有或没有辅料皮肤试验的疫苗接种咨询。
J Allergy Clin Immunol Glob. 2022 Nov;1(4):209-216. doi: 10.1016/j.jacig.2022.05.012. Epub 2022 Aug 13.
3
Allergic reactions to the coronavirus disease 2019 vaccine (ARCOV) study: The McGill University Health Centre experience.
新型冠状病毒疾病 2019 疫苗过敏反应（ARCOV）研究：麦吉尔大学健康中心的经验。
Ann Allergy Asthma Immunol. 2022 Aug;129(2):182-188.e1. doi: 10.1016/j.anai.2022.05.014. Epub 2022 May 21.
4
What have we learned about the allergenicity and adverse reactions associated with the severe acute respiratory syndrome coronavirus 2 vaccines: One year later.我们从与严重急性呼吸综合征冠状病毒 2 型疫苗相关的变应原性和不良反应中学到了什么：一年后。
Ann Allergy Asthma Immunol. 2022 Jul;129(1):40-51. doi: 10.1016/j.anai.2022.03.030. Epub 2022 Apr 4.
5
Coronavirus disease 2019 vaccine administration in patients with reported reactions to polyethylene glycol- and polysorbate-containing therapeutics.2019 年冠状病毒病疫苗在有报告称对含聚乙二醇和聚山梨酯的治疗药物有反应的患者中的给药。
Ann Allergy Asthma Immunol. 2022 Jul;129(1):88-94.e1. doi: 10.1016/j.anai.2022.03.006. Epub 2022 Mar 12.
6
Population-Based Incidence, Severity, and Risk Factors Associated with Treated Acute-Onset COVID-19 mRNA Vaccination-Associated Hypersensitivity Reactions.基于人群的急性发作 COVID-19 mRNA 疫苗接种相关过敏反应的发生率、严重程度及相关风险因素。
J Allergy Clin Immunol Pract. 2022 Mar;10(3):827-836. doi: 10.1016/j.jaip.2021.12.021. Epub 2021 Dec 29.